Denosumab, commonly known by the brand name Prolia, can reduce fracture risk in people for whom it is an appropriate osteoporosis treatment. Side effects are possible, but not everyone experiences them. Knowing which symptoms to discuss, which need urgent help and why injections should not be delayed without a treatment plan can make the decision easier to understand.
Key takeaways
- Denosumab is not a bisphosphonate. It is a different type of medicine, usually given for osteoporosis as a 60 mg injection every six months.
- Muscle, joint, bone and limb pain are recognised side effects. Persistent or severe symptoms deserve assessment rather than being dismissed as expected.
- Low blood calcium is an important safety concern. Your team should review calcium, vitamin D and kidney-related risks before treatment.
- Seek prompt help for warning symptoms. These include a hot, swollen area of skin, new unexplained thigh pain, or persistent mouth and jaw problems.
- Do not create your own treatment break. Delaying or stopping denosumab without a planned alternative can increase the risk of spinal fractures.
Reading a long medicine leaflet can be unsettling. A useful discussion puts possible harms alongside the benefit expected for your own fracture risk. The information below concerns osteoporosis-dose denosumab; other denosumab products and schedules used in cancer care should not be treated as interchangeable.
How does denosumab work?
Denosumab is an antibody medicine that blocks a signal called RANKL, reducing the activity of cells that break down bone. It is an antiresorptive treatment, but it belongs to a different drug class from alendronic acid or zoledronic acid.
Prolia is given as an injection under the skin, usually at a clinic or GP surgery. Whether it is suitable depends on your fracture risk, medical history, blood tests and ability to maintain the treatment schedule. Our osteoporosis treatment overview explains the wider range of options.
Which side effects are more common?
The UK Prolia patient leaflet lists bone, joint or muscle pain and arm or leg pain as very common, meaning they may affect more than one in ten people. Pain can sometimes be severe. That category describes a frequency in the medicine information; it does not predict what will happen to an individual.

Common listed effects include urinary symptoms, upper respiratory tract infections, sciatica, constipation, abdominal discomfort, rash, eczema and hair loss. Injection-site reactions are also reported. This is a practical summary, not a replacement for the full leaflet supplied with your medicine.
If a symptom starts after an injection, note when it began, how severe it is and whether it affects sleep or daily activities. A doctor or pharmacist can check other medicines and possible causes. There is no single reliable timetable for how long all side effects last, and a new symptom is not automatically caused by denosumab.
Low calcium: who needs closer monitoring?
Denosumab can lower calcium in the blood. Low calcium should be corrected before treatment, and your clinician will advise on adequate calcium and vitamin D intake and any supplements you need. Do not increase supplement doses on your own to try to prevent side effects.
The risk of significant hypocalcaemia is greater in people with severe kidney problems, particularly those receiving dialysis. Your team may arrange additional blood tests after an injection as well as checks beforehand. Tell them about kidney disease, problems absorbing nutrients and all medicines or supplements you take.
Get urgent medical advice if you develop muscle spasms, twitching or cramps, or tingling around the mouth, fingers or toes. The leaflet also warns about severe symptoms such as confusion, seizures or loss of consciousness. Call 999 for a seizure, collapse or another life-threatening emergency.
Other symptoms that should not wait
- Possible serious allergic reaction: swelling of the lips, mouth, tongue or throat, difficulty breathing or collapse requires emergency help. Call 999.
- Possible skin infection: a swollen, hot, tender area of skin, often on the lower leg, with or without fever needs prompt medical assessment. Redness can be less obvious on darker skin.
- New or unusual hip, groin or thigh pain: contact your doctor, because persistent unexplained pain can occasionally precede an unusual thigh-bone fracture.
- Mouth or jaw problems: tell your dentist and prescribing team promptly about pain, swelling, discharge, loose teeth or a sore that is not healing.
Unusual thigh fractures and osteonecrosis of the jaw are rare recognised complications. They should be taken seriously without assuming that ordinary aches or every dental problem represent these conditions. The right response is assessment and a coordinated plan.
Can I have dental treatment while taking Prolia?
Continue good oral hygiene and regular dental care. Tell your dentist that you receive denosumab and when your last and next injections are due. If you need an extraction, implant or other invasive procedure, your dentist and prescribing clinician should discuss the timing and your individual risks.
Do not cancel essential dental care or postpone an injection yourself because of a general warning online. Jaw-healing risk and the fracture risk associated with an unplanned denosumab delay need to be considered together.
Why stopping or delaying treatment needs a plan
Denosumab’s effects wear off relatively quickly when it is stopped. Some people experience rapid bone loss and multiple spinal fractures afterwards. NOGG guidance therefore advises having a long-term management plan before starting and avoiding unplanned cessation.
This does not mean you must tolerate an unsuitable medicine indefinitely. It means any decision to change treatment should include what happens next and when. A clinician may arrange another osteoporosis medicine to help protect your bones as denosumab wears off.
If an appointment is missed or the next injection is becoming overdue, contact the prescribing team promptly. Tell them about any side effects or dental plans rather than simply waiting until the following six-month appointment.
What to bring to your treatment review

A short written record makes the consultation more useful. Bring your injection dates, current medicines and supplements, recent blood results if available, and a description of symptoms. Include any falls, fractures, new back pain or dental procedures since the last review.
Ask: What benefit is expected for my fracture risk? Which blood tests do I need? Who should I contact between injections? When is my next dose due? If this medicine needs to change, what is the replacement plan?
A DEXA result is one part of that discussion. Treatment decisions also consider fractures, symptoms, other illnesses and how reliably the medicine can be continued.
Frequently asked questions
Is Prolia the same as denosumab?
Prolia is a brand of denosumab used at a 60 mg dose, usually every six months for osteoporosis. Denosumab is also used in other products and schedules for other conditions, so always check the exact medicine prescribed.
Does everyone get side effects?
No. Side effects are possible, but not everyone experiences them. Your clinician should explain the expected fracture-prevention benefit and the risks that matter most in your circumstances.
Can Prolia cause muscle or joint pain?
Yes. Bone, joint and muscle pain are recognised side effects. Severe, persistent or unusual pain should be assessed, particularly new pain in the thigh, hip or groin.
Can I take a drug holiday from denosumab?
A self-directed break is unsafe. Unlike a planned break from some bisphosphonates, stopping denosumab needs a specific clinical plan, usually involving another treatment to reduce the risk of rapid bone loss and spinal fractures.
Should I take extra calcium before an injection?
Follow the dose and preparation advice given by your prescribing team. They should assess calcium and vitamin D needs and arrange appropriate blood tests. Extra supplements are not a substitute for those checks.
Discuss your treatment and fracture risk
London Osteoporosis Clinic can review your bone health, treatment history and concerns as part of an individual assessment. Arrange a consultant appointment or check the current consultation fees. For an urgent reaction or an overdue injection, contact the team responsible for your prescription promptly rather than waiting for a routine appointment.
This article provides general information and does not replace advice from your prescribing clinician. Do not start, stop or change osteoporosis treatment based on this article. Seek urgent care for the warning symptoms described above.
References and further reading
- Amgen. Prolia 60 mg patient information leaflet, revised February 2026; accessed 4 November 2026.
- Royal Osteoporosis Society. Denosumab (Prolia); accessed 4 November 2026.
- National Osteoporosis Guideline Group. Pharmacological treatment options; accessed 4 November 2026.